Newcomer to NGS and RNAseq here. Very glad for the forum. Have already learned much and had many questions answered without having to ask!
-
-
I cannot figure out how to post a new thread. How did you do it?
Thanks -
In the upper left of the screen you'll see something like SEQanswers > Introductions > Hello Community. From there click on SEQanswers and it should take you to a page that lists the different forums. On the left of each forum will be a button that reads 'start new thread'. Hope this helps!Comment
-
Thanks, but for the life of me I can't find that button. I see a heading that says, Thread/Thread Starter, but cannot see a button to start a thread.Comment
-
Check out this series of screen shots and see if it helps. Red arrows show where to click.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...Yesterday, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment